Christine Moravec, PhD


Christine Moravec, Ph.D.

Appointed: 1993

Christine Moravec, PhD
Department: Molecular Cardiology
Associate Staff
Location: Cleveland Clinic Main Campus
Mail Code NE61
9500 Euclid Avenue
Cleveland, OH 44195
Christine Moravec, PhD
Department: Pediatric Institute
Associate Staff
Location: Cleveland Clinic Main Campus
Mail Code NE61
9500 Euclid Avenue
Cleveland, OH 44195
Both Adults and Children & Adolescents

Biographical Sketch

Christine Moravec, PhD, is a Staff Research Scientist and Director of Basic Research in the Kaufman Center for Heart Failure within the Robert and Suzanne Tomsich Department of Cardiovascular Medicine at Cleveland Clinic. Dr. Moravec is also one of three Associate Directors of the Bakken Heart-Brain Institute and holds secondary  appointments in the Department of Molecular Cardiology and the Center for Integrative Medicine. Her specialty interests include heart failure, cellular malfunction in cardiac dysfunction, drugs that may improve contractility of the failing heart, and remodeling of the failing heart using both surgical and psychophysiologic interventions. Dr. Moravec has a particular interest in mind-body medicine as it applies to cardiovascular disease, and is involved in several studies of psychophysiologic interventions designed to diminish overactivation of the autonomic nervous system in patients with cardiac disease. Dr. Moravec also runs the human heart tissue bank, which allows researchers at Cleveland Clinic to study the causes and possible treatments of human heart diseases.

Dr. Moravec attended John Carroll University in University Heights, Ohio, where she received a Bachelor of Arts degree in religious studies, followed by a Master of Science degree in biology. Dr. Moravec went on to pursue a PhD in regulatory biology from Cleveland State University, completing her research work for her dissertation at the Cleveland Clinic as a Graduate Student Fellow in the Department of Heart and Hypertension. She subsequently trained as a Postdoctoral Fellow in the Cleveland Clinic Department of Cardiovascular Biology, completing her specialty training in cellular physiology and electronmicroscopy. During her postdoctoral fellowship, Dr. Moravec was awarded a fellowship from the American Heart Association and also received the Tarazi Award for Cardiovascular Research at Cleveland Clinic.

Following postdoctoral training, Dr. Moravec moved on to the positions of Research Associate and Project Scientist within the Department of Cardiovascular Biology. Dr. Moravec joined the Professional Staff at Cleveland Clinic in 1993, in the Department of Molecular Cardiology, and she subsequently worked for eight years in the Center for Anesthesiology Research before joining the Kaufman Center for Heart Failure in 2002. Throughout her career, Dr. Moravec’s research interest has been understanding the cellular mechanisms of human heart failure and developing more therapeutic options for patients with heart failure.

In the past ten years, Dr. Moravec has been funded by both local and national American Heart Association (AHA) as well as the National Institutes of Health (NIH) as she has studied the mechanisms of human heart failure. Her work is currently supported by a five-year grant from the NIH and a three-year grant from the AHA, as well as a pilot grant from the Bakken Heart-Brain Institute. In 1995, Dr. Moravec was named an Established Investigator of the American Heart Association. Dr. Moravec has also served as a research mentor for both predoctoral and postdoctoral fellows who have obtained fellowship grants from either the AHA or NIH, and has hosted numerous undergraduate summer students who have been supported by the AHA.

In addition to her research work, Dr. Moravec holds academic appointments in the Department of Molecular Medicine at Case Western Reserve University School of Medicine and in the Department of Biology, Geology and Environmental Sciences at Cleveland State University. She is a member of the Curriculum Development Task Force for the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, serves as Chair of Graduate Studies within the Lerner Research Institute  and coordinates the Heart Failure Research Seminars and Bakken Heart-Brain Journal Clubs. Dr. Moravec also currently serves as President of the Board of Directors of the Northeastern Ohio Science and Engineering Fair, a regional science fair held each spring for 600 students from the Cleveland area.

Widely published in peer-reviewed scientific journals such as the Journal of Biological Chemistry, Circulation, Circulation Research, Proceedings of the National Academy of Sciences, and the Journal of Molecular and Cellular Cardiology, Dr. Moravec has authored numerous journal articles and abstracts describing work in her laboratory. She serves as a reviewer for scientific journals including Circulation, Circulation Research, the American Journal of Physiology, Cardiovascular Research, the Journal of Molecular and Cellular Cardiology and the Journal of Pharmacology and Experimental Therapeutics, and is a member of local and national AHA peer-review study sections.

Dr. Moravec has been invited to present her research at national and international meetings and conferences. She is a member of the American Physiological Society, American Heart Association, Heart Failure Society of America, American Psychosomatic Association, American Association for Applied Psychophysiology and Biofeedback and the International Society for Heart & Lung Transplantation.

Professional Highlights

  • Director of Basic Research, Kaufman Center for Heart Failure, Cleveland Clinic
  • Outstanding Educator Award, Lerner Research Institute, Cleveland Clinic

Education & Fellowships

Doctorate - Cleveland State University
Cleveland, OH USA
Graduate - John Carroll University
University Heights, OH USA
Undergraduate - John Carroll University
University Heights, OH USA

Awards & Honors

Established Investigator of the American Heart Association

Additional Training

  • Postdoctoral Fellowship, Cell Physiology, Cleveland Clinic


  • American Heart Association
  • Heart Failure Society of America
  • American Psychosomatic Society
  • American Physiological Society
  • American Association for Applied Psychophysiology and Biofeedback

Treatment & Services

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 6/8/2014, Dr. Moravec has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English
Cleveland Clinic Mobile Site